All Type of News
Introduction of the revised Opticians Law to put the ophthalmology industry on alert
As enactment of an Act to practically allow opticians to have a part of ophthalmic practice has become visible, it has put the ophthalmology industry on alert.
The Amendment to the Opticians Law proposed by Assemblyp...
Domestic pharmaceutical companies as Central & South America Health Medical Mission
The 2015 Central & South America Health Medical Mission, which is scheduled to be dispatched within this month, will be participated by 3 domestic pharmaceutical companies.
It was known Daewoong Pharmaceutical, Korea...
Ilyang Pharmaceutical’s new ‘ER—GMP level’ factory for SupectIlyang Pharmaceutical(CEO Dong-yeon Kim) had a ceremony for completion of a manufacturing facility exclusively for “Supect,” a chronic myeloid leukemia, at the BioValley located...
|
Expanded Health Insurance Benefit of ‘Invega Sustenna’
Janssen Korea(CEO Ok-yeon Kim) announced the health insurance standard of Invega Sustenna(generic name: paliperidone palmitate), a schizophrenia treatment, will be changed from the 1st under the Ministry of Health and...
The government to allow hospitals to establish medical device companies
The government is planning to invest funds over KRW 50 billion for the next 5 years to nurture the medical device industry. In order to encourage participation of hospitals, it has allowed them to establish an own med...
Price is the key in hepatitis C treatments directly sold from other countries
In the domestic hepatitis C treatment market, new drugs which were proved to have shorter treatment periods and less side effects have started to distinguish themselves one by one.
However, on the other side of all t...
Improvement plan for Domestic biosimilar drug assessment to be finalized
As the government included the biopharmaceutical industry in the target for the relaxation policy of regulation, the Ministry of Health and Welfare(MOHW) is planning to finalize the improvement plan for drug price ass...
Stock prices of 10 pharmaceuticals increased by more than 200%
It was observed stocks of listed pharmaceutical companies were increased by more than 100% compared with the late last-year.
Particularly, stocks of 10 companies, such as Hanmi Science, Samsung Pharm and Hanmi Pharm,...
Ahngook Pharm’s osteoporosis treatment, ‘Binosto Effervescent Tab’ to be approvedAhngook Pharm(President Uh Jin) has completed domestic approval of Binosto Effervescent Tab(alendronate sodium 70mg), a bisphosphonate-type osteoporosis treatment, on Oct. 14.
...
|
Samsung to aim to become biopharmaceutical power
While the number of patents registered as biopharmaceutical product has continuously increased for the past 5 years, it was observed Samsung Electronics filed the most number of applications for antibody patent, also ...
